Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-04-12
1998-09-15
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 13, 514 14, 514 15, 514 16, 514 17, 530317, 530324, 530325, 530326, 530327, 530328, 530329, A61K 3808, A61K 3810, A61K 3812, A61K 3816
Patent
active
058078193
ABSTRACT:
The present invention provides Arg--Gly--Asp peptides that can alter the binding of osteoclasts to a matrix such as bone or can selectively alter integrin receptor binding. The invention also provides methods of using the Arg--Gly--Asp peptides to alter .alpha..sub.V .beta..sub.3 integrin receptor-mediated binding of a cell such as an osteoclast, endothelial cell or smooth muscle cell to a matrix. The invention further provides methods for ameliorating the severity of a pathology characterized, in part, by an undesirable level of bone resorption, angiogenesis or restenosis in a subject.
REFERENCES:
patent: 4517686 (1985-05-01), Ruoslahti et al.
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4589881 (1986-05-01), Pierschbacher et al.
patent: 4614517 (1986-09-01), Ruoslahti et al.
patent: 4654314 (1987-03-01), Takagi et al.
patent: 4661111 (1987-04-01), Ruoslahti et al.
patent: 4792525 (1988-12-01), Ruoslahti et al.
patent: 5041380 (1991-08-01), Ruoslahti et al.
patent: 5192746 (1993-03-01), Lobl et al.
patent: 5227469 (1993-07-01), Lazarus et al.
Aumailley et al., "Arg-Gly-Asp Constrained within Cyclic Pentapeptides Strong and Selective Inhibitors of Cell Adhesion to Vitronectin and Laminin Fragment P1," FEBS Letters 291(1):50-54 (1991).
Choi et al., "Inhibition of Neointimal Hyperplasia by Blocking .alpha..sub.v .beta..sub.3 Integrin with a Small Peptide Antagonist GpenGRGDSPCA," J. Vascular Surg. 19(1):125-134 (1994).
Fauchere et al., "Modulation of the Activity and Assessment of the Receptor Selectivity in a Series of New RGD-containing Peptides," Int'l J. Peptide & Protein Res. 42(5):440-444 (1993).
PCT Search Report (dated 9 Nov. 1995), International application No. PCT/US95/04741.
Nesbitt, Stephen et al., "Biochemical Characterization of Human Osteoclast Integrins." J. Biol. Chem. 268:16737-16745 (1993).
Hughes, D.E. et al., "Integrin Expression in Human Bone." J. Bone & Mineral Res. 8:527-533 (1993).
Ross, R. Patrick et al., "Interactions Between the Bone Matrix Proteins Osteopontin and Bone Sialoprotein and the Osteoclast Integrin .alpha..sub.v .beta..sub.3 Potentiate Bone Resorption." J. Biol. Chem. 268:9901-9907 (1993).
Chuntharapai Anan et al., "Blocking Monoclonal Antibodies to .alpha..sub.v .beta..sub.3 Integrin: A Unique Epitope of .alpha..sub.v .beta..sub.3 Integrin is Present on Human Osteoclasts." Experimental Cell Res. 205:345-352 (1993).
Helfrich, Miep H. et al., "Rat Osteoclasts Adhere to a Wide Range of RGD (Arg-Gly-Asp) Peptide-Containing Proteins, Including the Bone Sialoproteins and Fibronectin, via a .beta..sub.3 Integrin." J. Bone and Mineral Res. 7:335-343 (1992).
Miyauchi, Akimitsu et al., "Recognition of Osteopontin and Related Peptides by an .alpha..sub.v .beta..sub.3 Integrin Stimulates Immediate Cell Signals in Osteoclasts." J. Biol. Chem. 266:20369-20374 (1991).
Yamakawa, Kensuke et al., "An Arg-Gly-Asp Peptide Stimulates Ca.sup.2+ Efflux From Osteoclast Precursors Through a Novel Mechanism." American Physiological Society. 651-657 (1994).
Horton, M.A. et al., "Arg-Gly-Asp (RGD) Peptides and the Anti-Vitronectin Receptor Antibody 23c6 Inhibit Dentine Resorption and Cell Spreading by Osteoclasts." Experimental Cell Res. 195:368-375 (1991).
Horton, Michael A. et al., "Modulation of Vitronectin Receptor-Mediated Osteoclast Adhesion by Arg-Gly-Asp Peptide Analogs: A Structure-Function Analysis." J. Bone and Mineral Res. 8:239-247 (1993).
Sato, M. et al., "Echistatin is a Potent Inhibitor of Bone Resorption in Culture." J. Cell Biol. 111:1713-1723 (1990).
Cheng Soan
Ingram Ronald
Mullen Daniel
Tschopp Juerg F.
La Jolla Cancer Research Center
Russel Jeffrey E.
LandOfFree
Peptides useful for altering bone resorption does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides useful for altering bone resorption, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides useful for altering bone resorption will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-86901